Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CK.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CK.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.27EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.27ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.27ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.27EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.27EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.27EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.27ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.27ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.27EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.27EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DV.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
DV.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DV.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DV.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DV.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
CH.1.1.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CH.1.1.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CH.1.1.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CH.1.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.26EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.26ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
CH.1.1.26ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CH.1.1.26EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CH.1.1.26EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CH.1.1.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DV.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
DV.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DV.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DV.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DV.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used